Latest autoimmune diseases Stories
Pre-clinical study data published in PNAS ROSH HAAYIN, Israel, February 19, 2015 /PRNewswire/ -- Beta-O2 announced today the results of a series of pre-clinical
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
LifeScienceIndustryResearch.com adds “OpportunityAnalyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023” report to its store. Dallas, TX
TORONTO, Feb. 17, 2015 /CNW/ - Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a promising new approach to treat multiple sclerosis (MS).
PORTLAND, Ore., Feb.
-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) LAKE FOREST, Ill., Feb.
CCFA, AGA and Janssen Biotech Announce New Grant Program NEW YORK, Feb.
MISSISSAUGA, ON, Feb. 12, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc.
CRANBURY, N.J., Feb.
-- CHABLIS-SC1 study passes futility analysis and will continue to completion with an enhanced endpoint HAYWARD, Calif., Feb.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.